体外受精 (IVF) 市场规模、份额和成长分析：按週期、按程序、按最终用途、按地区 - 行业预测，2024-2031 年

2022 年，全球体外受精 (IVF) 市场规模将达到 242 亿美元，从 2023 年的 260.9 亿美元增至 2031 年的 475.4 亿美元，预计在预测期内（2024-2031 年）将成长。率为7.79%。

全球体外受精（IVF）市场包括辅助生殖技术（ART）领域，其中卵子受精在人类体外进行。体外受精（IVF）已成为解决不孕症和帮助夫妻怀孕的一种有前景的方法。这个过程通常涉及卵巢刺激、取卵、受精和胚胎移植。体外受精（IVF）市场的主要目标是为患有不孕症的夫妻提供一种解决方案，在自然方法不足或不太可能成功时提供一条成功怀孕的途径。全球不孕率上升是由于生活方式改变、延迟分娩、荷尔蒙异常和医疗状况等因素造成的，这些因素推动了对体外受精 (IVF) 的需求。体外受精 (IVF) 的技术进步——包括改进的实验室技术、改进的冷冻保存方法和先进的基因检测——显着提高了成功率。这些进步吸引了寻求可靠生育治疗方法的夫妻。然而，治疗的复杂性、成功率的不确定性和心理压力等挑战可能会阻碍体外受精 (IVF)。随着人们意识的提高和不孕症治疗的普及，体外受精 (IVF) 的需求不断增长，尤其是在新兴市场，这推动了市场的扩张。这为这些地区建立体外受精（IVF）诊所和加强服务创造了机会。持续的技术创新和新兴市场不断增长的需求为体外受精 (IVF) 行业带来了巨大的成长机会，并有望提高成功率并改善患者体验。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场成功因素
• 竞争程度
• 主要投资机会
• 市场吸引力指数
• 生态系绘图
• 价格分析
• 价值链分析

体外受精 (IVF) 市场：依週期

• 新鲜的非捐赠者
• 冷冻非捐赠者
• 新的捐赠者
• 冷冻供体

体外受精 (IVF) 市场：依最终用途分类

• 生育诊所/体外受精 (IVF) 中心
• 手术中心
• 医院
• 研究所
• 冷冻银行

体外受精 (IVF) 市场：依治疗方式

• 传统体外受精（IVF）
• 体外受精 (IVF)/显微授精
• 最小体外受精（IVF）
• 使用捐赠卵子进行体外受精 (IVF)
• 其他的

体外受精 (IVF) 市场：副产品

• 装置
  • 影像系统
  • 精子分离系统
  • 抽卵子泵
  • 显微作业系统
  • 培养箱
  • 延时培养箱
  • 其他培养箱
  • 气体分析仪
  • 雷射系统
  • 冷冻系统
  • 内阁
  • 防震台
  • 见证系统
  • 配件
• 试剂/介质
  • 胚胎培养基
  • 冷冻保存介质
  • 精子处理培养基
  • 卵子处理培养基

体外受精 (IVF) 市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Vitrolife AB (Sweden)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Cook Medical (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Merck KGaA (Germany)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Thermo Fisher Scientific, Inc. (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Esco Micro Pte Ltd (Singapore)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Genea Limited (Australia)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Ferring Pharmaceuticals (Switzerland)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Hamilton Thorne, Inc. (Canada)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Nidacon International AB (Sweden)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Rocket Medical plc (UK)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• EMD Serono (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Kitazato Corporation (Japan)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• IVFtech Aps (Denmark)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Zeiss Group (Germany)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Labotect GmbH (Germany)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Esco Medical (Singapore)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• The Baker Company, Inc. (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Boston IVF (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Invitrocare Fertility Laboratories Pvt. Ltd. (India)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• EMD Serono, Inc. (US)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势
• Fujifilm Holdings Corporation (Japan)
  • 公司简介
  • 事业部概况
  • 财务更新
  • 主要趋势

Global In Vitro Fertilization Market size was valued at USD 24.20 Billion in 2022 and is poised to grow from USD 26.09 Billion in 2023 to USD 47.54 Billion by 2031, at a CAGR of 7.79% during the forecast period (2024- 2031).

The global in vitro fertilization (IVF) market encompasses the field of assisted reproductive technology (ART), where egg fertilization occurs outside the human body. IVF has become a prominent method for addressing infertility and helping couples achieve pregnancy. The process typically includes ovarian stimulation, egg retrieval, fertilization, and embryo transfer. The primary aim of the IVF market is to provide solutions for couples struggling with fertility issues, offering them a pathway to successful conception when natural methods are insufficient or unlikely to succeed. Increasing global infertility rates, driven by factors such as lifestyle changes, delayed childbearing, hormonal disorders, and medical conditions, have intensified the demand for IVF. Technological advancements in IVF-such as enhanced laboratory techniques, improved cryopreservation methods, and advanced genetic testing-have significantly boosted success rates. These improvements have attracted couples seeking reliable fertility solutions. However, challenges such as the complexity of treatment, uncertainties about success rates, and emotional stress can deter some individuals from pursuing IVF. The demand for IVF is growing particularly in developing regions, where increased awareness and better access to fertility treatments are facilitating market expansion. This presents opportunities for establishing IVF clinics and enhancing services in these areas. The ongoing technological innovations and rising demand from emerging markets represent significant growth opportunities for the IVF industry, promising improved success rates and better patient experiences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Fertilization Market Segmental Analysis

The global in vitro fertilization market is segmented based on cycle, end-user, procedure, product, and region. Based on cycle, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor. In terms of end-user, the market is segmented into Fertility Clinics & IVF Centers, Surgical Centers, Hospitals, Research Institutes, Cryobanks. Based on procedure, the market is segmented into Conventional IVF, IVF with ICSI, Minimal IVF, IVF with Donar Eggs, Others. Based on product, the market is segmented into Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators {Time-lapse incubators, Other incubators}, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, IVF Cabinets, Anti-vibration Tables, Witness Systems), Reagents & Media (Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media), Accessories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global In Vitro Fertilization Market

Rising awareness about infertility and the accessibility of IVF treatments have led to greater acceptance and demand for IVF procedures. As more individuals learn about these options, the stigma surrounding infertility has diminished. Public figures and celebrities who openly discuss their IVF experiences have played a crucial role in normalizing the procedure. Their stories have helped break down barriers, making IVF a more accepted and considered choice for those facing fertility challenges.

Restraints in the Global In Vitro Fertilization Market

IVF procedures raise several ethical and legal issues, including the use of donor gametes, embryo storage, and embryo selection. These concerns introduce regulatory complexities and result in differing IVF practices across various countries and regions. These variations can affect the growth and standardization of the IVF market, as different jurisdictions implement their own regulations and guidelines, leading to inconsistent practices and market dynamics.

Market Trends of the Global In Vitro Fertilization Market

In 2023, personalized medicine emerged as a significant trend in the IVF market. This approach focuses on customizing IVF treatment protocols according to individual patient factors, such as age, ovarian reserve, and specific fertility issues. The goal of personalized medicine is to enhance treatment outcomes and increase the efficiency of IVF procedures by tailoring interventions to meet the unique needs of each patient. This method aims to improve the overall effectiveness and success rates of IVF treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Pricing Analysis
• Value Chain Analysis

In-Vitro Fertilization Market by Cycle

• Fresh Non-Donor
• Frozen Non-Donor
• Fresh Donor
• Frozen Donor

In-Vitro Fertilization Market by End Use

• Fertility Clinics & IVF Centers
• Surgical Centers
• Hospitals
• Research Institutes
• Cryobanks

In-Vitro Fertilization Market by Procedure

• Conventional IVF
• IVF with ICSI
• Minimal IVF
• IVF with Donor Eggs
• Others

In-Vitro Fertilization Market by Product

• Equipment
  • Imaging Systems
  • Sperm Separation System
  • Ovum Aspiration Pumps
  • Micromanipulator System
  • Incubators
  • Time-lapse incubators
  • Other incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Cabinets
  • Antivibration Tables
  • Witness Systems
  • Accessories
• Reagents and Media
  • Embryo Culture Media
  • Cryopreservation Media
  • Sperm Processing Media
  • Ovum Processing Media

In-Vitro Fertilization Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profile

• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte Ltd (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocket Medical plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVFtech Aps (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labotect GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Baker Company, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitrocare Fertility Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments